Cutaneous Oncology News

Second primary melanomas are more likely to develop in patients with more nevi and a high genetic predisposition to melanoma, according to a study.

Sentinel lymph node biopsy was effective as a prognostic and staging tool in stage IIB/C melanoma, according to a study.

The presence of microsatellites was associated with poorer overall survival in a retrospective cohort of patients with cutaneous melanoma, according to a study.

Fecal microbiota transplant from healthy donors may lower primary resistance to immunotherapy with anti-PD-1 agents among patients with advanced or metastatic melanoma, results of the phase 1 MIMic trial showed.

The FDA granted orphan drug designation to AVS100 for the treatment of stage IIB through stage IV melanoma, according to the agent’s manufacturer.

A single dose of lifileucel conferred an objective response in nearly one-third of patients with advanced unresectable or metastatic melanoma, results from the phase 2 C-144-01 trial showed.

Response-adapted therapy in melanoma, which involves removal of certain immunotherapeutic agents in a combination, can reduce costs without a decrease in efficacy, according to a study.

A greater proportion of patients with cutaneous T-cell lymphoma and sepsis were older, Black and experienced more sepsis episodes compared with patients with sepsis and a different type of non-Hodgkin lymphoma, according to a study.

Sunburns early in life may be associated with melanoma or cutaneous squamous cell carcinoma later in life, according to a study.

Among patients with T1a cutaneous melanomas, younger age and tumors in the head/neck region were most likely to demonstrate sentinel lymph node positivity, according to a study.